Login / Signup
Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study.
Taro Kishi
Yasuhiro Iwama
Yuji Sasagawa
Shuichi Hiraoka
Aya Kamei
Nakao Iwata
Published in:
Psychiatry and clinical neurosciences (2023)
Keyphrases
</>
open label
bipolar disorder
clinical trial
squamous cell carcinoma
phase iii
double blind